Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...

The products are being advertised as more affordable alternatives to blockbuster weight-loss drugs. Here's what doctors think ...

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and ...

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be ...

GLP-1 drugs like Ozempic, Mounjaro, Wegovy, and Zepbound are powerful tools for treating diabetes and aiding with weight loss ...

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...

Kourtney Kardashian’s new “GLP-1 Daily” pill is the latest product to capitalize on the weight loss drug craze.

Cost (18 per cent) is the major reason identified in the survey, followed by not being covered by insurance (15 per cent), ...

In a recent study conducted by a team from The Ohio State University, US, it was revealed that a staggering 25% of adults, or ...

LifeMD's Q2 earnings highlight mixed results and other issues, and the potential for high risk with high returns. Click here ...

(Bloomberg) — Sandoz Group AG plans to launch a semaglutide generic drug in Canada when the patent for the main ingredient of blockbuster diabetic and weight-loss drugs like Ozempic and Wegovy ...

Here are key takeaways from latest research and a session of the European Association of the Study of Diabetes (EASD) ...